-- 根據週四提交深圳證券交易所的披露文件顯示，吉爾吉斯斯坦藥品監管機構已批准河北常山生化藥業（深交所代碼：300255）的肝素鈉注射液上市。 文件指出，該藥物用於治療血栓或栓塞性疾病，具有抗凝血作用，可預防血栓形成。
Related Articles
Mining & Metals
Wedbush Refines Fennec Pharmaceuticals Estimates Ahead of Q1 Earnings
Wedbush is refining its its 2026 estimates for Fennec Pharmaceuticals (FRX.TO) ahead of the company reporting its fiscal first-quarter results."While we believe underlying demand trends remain intact, we are refining our 2026 estimates to reflect anticipated seasonality and the near-term impact of recent commercial reinvestment. Given onboarding and ramp dynamics, we do not expect meaningful contribution from new hires until 2H26 and anticipate limited sequential growth in 1H26," writes analyst David Nierengarten, who is maintaining an outperform and US$13.00 price target on the stock.Nierengarten forecasts first-quarter Pedmark revenue of US$13. million (~flat q/q), with a similar setup in the second quarter, before growth reaccelerates in the second half of the year as sales force productivity improves and the adolescent and young adult (AYA) penetration builds. (Pedmark is an injection used to lower the risk of hearing-loss induced by cisplatin chemotherapy)For fiscal 2026, Nierengarten expects Pedmark revenue of ~US$62 million (+39% y/y), with the back-half weighting driven by incremental contribution from new commercial hires."We continue to view Pedmark as a durable growth asset with a clear path to re-acceleration in 2H26, with FENC on track to achieve cash flow positivity in 2026, supporting a constructive outlook on shares."Price: $8.75, Change: $+0.10, Percent Change: +1.16%
$FENC$FRX.TO
Mining & Metals
Coyote Copper Mines Up 28% as it Starts Exploration Work on New Sulphide Copper Zone
Coyote Copper Mines (CCMM.V) shares rose 28% on Thursday after it announced the start of work on a newly discovered zone, with exposed copper sulphide mineralization and magmatic breccias within the Copper Triangle of Arizona.The company said channel samples are being cut with a diamond saw and dispatched to American Assayers Laboratories in Sparks, Nevada for analysis.Recent field efforts have led to the identification of a new mineralized zone, which includes a breccia pipe referred to as the Maher Breccia. It said broader zone remains under active evaluation, with current project mapping indicating a strike length of more than 4 km and a width exceeding 600 m.Shares of the company were last seen up $0.055 to $0.25 on the TSX Venture Exchange.Price: $0.25, Change: $+0.06, Percent Change: +28.21%
$CCMM.V
Australia
Procter & Gamble Advises Shareholders to Reject Potemkin Mini-Tender Offer
Procter & Gamble (PG) said Thursday it has it been notified of an unsolicited mini-tender offer from Potemkin to buy up to 100,000 shares of the company at $100 each.The company said this is the second such offer in the last few weeks and recommends that shareholders do not accept it, saying the offer is below the market price, comes with conditions, and is not endorsed by the company.Procter & Gamble shares were little changed at around $143.35 in trading on Thursday.Price: $143.52, Change: $+0.14, Percent Change: +0.10%
$PG